Pharma Stocks Outlook for the week – 29.06.2015 to 03.07.2015
Seen
outperforming broader market next week
( www.rupeedesk.in )
Stocks
of frontline pharmaceutical companies are likely to outperform the broader
market next week as there is a
continuous positive momentum in the sector. Stocks of Dr Reddy's Laboratories
Ltd, Lupin Ltd and Alembic Pharmaceuticals Ltd are seen better than peers in
the sector. There is positive momentum in pharma stocks and it is seen
continuing next week. Stocks of Alembic Pharmaceuticals are also seen positive
based on the approval received by the company from the US Food and Drug
Administration to sell generic of anti-inflammatory drug Celecoxib. Though the
drug is tentatively approved and already being sold by many competitors, we
believe the drug can contribute to the overall sales, given the size of the company
when approved.
